as on January 28, 2026 at 9:40 pm IST
Day's Low
Day's High
1.04%
Downside
0.62%
Upside
52 Week's Low
52 Week's High
20.62%
Downside
10.75%
Upside
Check Catalyst Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
2.5417
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.20%
PE Ratio (TTM)
14.03
Industry PE ratio
5.553333333333334
PEG Ratio
0EBITDA
296.6M
Revenue (TTM)
578.2M
Profit Margin
37.63%
Return On Equity TTM
27.52%
Track how Catalyst Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Catalyst Pharmaceuticals Inc in the last 5 years
Lowest (10.45x)
March 31, 2021
Industry (5.55x)
January 28, 2026
Today (14.03x)
January 28, 2026
Highest (28.83x)
June 30, 2024
Today’s Price to Earnings Ratio: 14.03x
Compare market cap, revenue, PE, and other key metrics of Catalyst Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.9B | 568.61% | 14.03 | 37.63% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Catalyst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Catalyst Pharmaceuticals Inc investment value today
Current value as on today
₹1,11,053
Returns
₹11,053
(+11.05%)
Returns from Catalyst Pharmaceuticals Inc Stock
₹5,079 (+5.08%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Catalyst Pharmaceuticals Inc. Average target price of $34.86
Get share price movements and forecasts by analysts on Catalyst Pharmaceuticals Inc.
What analysts predicted
31.15%UPSIDE
Target Price
$34.86
Current Price
$24
Analyzed by
13 Analysts
Target
$34.86
Catalyst Pharmaceuticals Inc target price $34.86, a slight upside of 31.15% compared to current price of $24. According to 13 analysts rating.
Search interest for Catalyst Pharmaceuticals Inc Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:57% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, CPRX stock has moved up by 12.7%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 52.10M → 52.78M (in $), with an average increase of 1.3% per quarter
Best in 3 Years
![]()
In the last 3 years, CPRX has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 141.42M → 148.39M (in $), with an average increase of 2.4% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 42.9%
| Organisation | Catalyst Pharmaceuticals Inc |
| Headquarters | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
| Industry | Health Technology |
| CEO | Mr. Richard John Daly M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Richard John Daly M.B.A. | President, CEO & Director |
Mr. Michael W. Kalb CPA | Executive VP, Treasurer & CFO |
Mr. Jeffrey Del Carmen | Executive VP & Chief Commercial Officer |
Ms. Mary Coleman | VP & Head of Investor Relations |
Mr. Brian Elsbernd J.D. | Chief Compliance Officer & Chief Legal Officer |
Dr. William T. Andrews FACP, M.D. | Chief Medical Officer |
Mr. Philip B. Schwartz Esq. | Corporate Secretary |
Dr. Steven R. Miller Ph.D. | Executive VP, COO & Chief Scientific Officer |
Dr. Preethi Sundaram Ph.D. | Chief Strategy Officer |
Mr. Gregg Russo | Chief Human Resources Officer |
Catalyst Pharmaceuticals Inc share price today is $24 as on . Catalyst Pharmaceuticals Inc share today touched a day high of $24.15 and a low of $23.75.
Catalyst Pharmaceuticals Inc share touched a 52 week high of $26.58 on and a 52 week low of $19.05 on . Catalyst Pharmaceuticals Inc stock price today i.e. is trending at $24,which is 9.71% down from its 52 week high and 25.98% up from its 52 week low.
Catalyst Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Catalyst Pharmaceuticals Inc (CPRX) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Catalyst Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Catalyst Pharmaceuticals Inc share’s latest price of $24 as on January 28, 2026 at 9:40 pm IST, you will get 0.4167 shares of Catalyst Pharmaceuticals Inc. Learn more about
fractional shares .
Catalyst Pharmaceuticals Inc stock has given 568.61% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?